Gliknik Inc. developed a Trojan cancer vaccine, consisting of chemically synthetized long peptides, containing 2 or 3 CD4 and CD8 specific epitopes from either MAGE or HPV Ag, fused to the TAT CPP. Here, CD8A is linked to cancer.